Intravitreal Bevacizumab for Idiopathic Choroidal Neovascularization After Previous Injection With Posterior Subtenon Triamcinolone
- 31 March 2007
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 143 (3), 507-509.e1
- https://doi.org/10.1016/j.ajo.2006.10.050
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopiaBritish Journal of Ophthalmology, 2007
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young femalesAmerican Journal of Ophthalmology, 2004
- Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case seriesOphthalmology, 2003
- The use of corticosteroids for choroidal neovascularisation in young patientsEye, 1998